COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 1811: Articles 18101-18110  | Next

Invasive Mould Disease in Fatal COVID-1 19: A Systematic Review of Autopsies
Kula, B., Clancy, C. J., Nguyen, M. H., Schwartz, I. S.
10.1101/2021.01.13.21249761 — Posted: 2021-01-20
The Association of COVID-19 Incidence with Sport and Face Mask Use in United States High School Athletes
Watson, A., Haraldsdottir, K., Biese, K., Goodavish, L., Stevens, B., McGuine, T.
10.1101/2021.01.19.21250116 — Posted: 2021-01-20
Impact of immediate and preferential relaxation of social and travel restrictions for vaccinated people on the spreading dynamics of COVID-19 : a model-based analysis
Shayak, B., Sharma, M. M., Mishra, A. K.
10.1101/2021.01.19.21250100 — Posted: 2021-01-20
Hyperinflammatory conditions, gender differences and mortality in Indian COVID-19 patients
Shoeb, F., Hussain, I., Afrin, G., Mufti, S. T., Raza, S. T., Mahdi, F.
10.1101/2021.01.19.21250134 — Posted: 2021-01-20
Spatio-temporal analysis between the incidence of COVID-19 and human development in Mato Grosso do Sul, Brazil.
Souza, A., Abreu, M. C., de Oliveira Junior, J. F.
10.1101/2021.01.19.21250106 — Posted: 2021-01-20
Modeling the population effects of epitope specific escape mutations in SARS-CoV-2 to guide vaccination strategies
Koopman, J. S., Simon, C. P., Getz, W. M., Salter, R.
10.1101/2021.01.19.21250114 — Posted: 2021-01-20
A Label-Free SARS-CoV-2 Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients
Luo, Y. R., Yun, C., Chakraborty, I., Wu, A. H. B., Lynch, K. L.
10.1101/2021.01.19.21250137 — Posted: 2021-01-20
Overcrowding and Exposure to Secondhand Smoke Increase Risk for COVID-19 Infection Among Latinx Families in Greater San Francisco Bay Area
DeCastro Mendez, A., Escobar, M., Romero Encinas, M., Wojcicki, J.
10.1101/2021.01.19.21250139 — Posted: 2021-01-20
Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19
Syed, F., Li, W., Relich, R. F., Russell, P. M., Zhang, S., Zimmerman, M. K., Yu, Q.
10.1101/2021.01.19.21250115 — Posted: 2021-01-20
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Rathnasinghe, R., Jangra, S., Cupic, A., Martinez-Romero, C., Mulder, L. C. F., Kehrer, T., Yildiz, S., Choi, A., Mena, I., De Vrieze, J., Aslam, S., Stadlbauer, D., Meekins, D. A., McDowell, C. D., Balaraman, V., Richt, J. A., De Geest, B. G., Miorin, L., Personalized Virology Initiative, , Krammer, F., Simon, V., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.19.21249592 — Posted: 2021-01-20 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).